פולבסטרנט סנדוז
novartis israel ltd - fulvestrant - תמיסה להזרקה - fulvestrant 50 mg/ml - fulvestrant
סיגניפור לאר 10 מג
medison pharma ltd - pasireotide as pamoate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as pamoate 10 mg/vial - pasireotide
סיגניפור לאר 30 מג
medison pharma ltd - pasireotide as pamoate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as pamoate 30 mg/vial - pasireotide
פליפרידון טבע 100 מג
teva israel ltd - paliperidone palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone palmitate 100 mg / 1 ml - paliperidone
פליפרידון טבע 150 מג
teva israel ltd - paliperidone as palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone as palmitate 100 mg / 1 ml - paliperidone
פליפרידון טבע 25 מג
teva israel ltd - paliperidone as palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone as palmitate 100 mg / 1 ml - paliperidone
פליפרידון טבע 50 מג
teva israel ltd - paliperidone palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone palmitate 100 mg / 1 ml - paliperidone
פליפרידון טבע 75 מג
teva israel ltd - paliperidone as palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone as palmitate 100 mg / 1 ml - paliperidone
ג'נואט 50 מג500 מג
merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - טבליה - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 500 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.
ג'נואט 50 מג850 מג
merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - טבליה - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 850 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.